Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 952159, 3 pages
http://dx.doi.org/10.1155/2014/952159
Editorial

Autoimmune Rheumatic Diseases

1Center for Autoimmune Diseases Research (CREA), Universidad del Rosario, Carrera 24 No. 63C-69, 111221 Bogota, Colombia
2Zabludowitcz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, 52621 Tel-Hashomer, Israel
3Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Charitéplatz 1, 10117 Berlin, Germany
4Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Avenida de Valdecilla, s/n, Cantabria, 39008 Santander, Spain

Received 17 July 2014; Accepted 17 July 2014; Published 5 August 2014

Copyright © 2014 Juan-Manuel Anaya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Anaya, “Common mechanisms of autoimmune diseases (the autoimmune tautology),” Autoimmunity Reviews, vol. 11, no. 11, pp. 781–784, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Solovieff, C. Cotsapas, P. H. Lee, S. M. Purcell, and J. W. Smoller, “Pleiotropy in complex traits: challenges and strategies,” Nature Reviews Genetics, vol. 14, no. 7, pp. 483–495, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Shoenfeld, R. Gerli, A. Doria et al., “Accelerated atherosclerosis in autoimmune rheumatic diseases,” Circulation, vol. 112, no. 21, pp. 3337–3347, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Navarro, L. Candia-Zúñiga, L. H. Silveira et al., “Vascular endothelial growth factor plasma levels in patients with systemic lupus erythematosus and primary antiphospholipid syndrome,” Lupus, vol. 11, no. 1, pp. 21–24, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. G. J. Pons-Estel, R. Serrano, M. A. Plasín, G. Espinosa, and R. Cervera, “Epidemiology and management of refractory lupus nephritis,” Autoimmunity Reviews, vol. 10, no. 11, pp. 655–663, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. M. T. Arango, Y. Shoenfeld, R. Cervera, and J. M. Anaya, “Infection and autoimmune diseases,” in Autoimmunity. From Bench to Bedside, J. M. Anaya, Y. Shoenfeld, A. Rojas-Villarraga, R. A. Levy, and R. Cervera, Eds., pp. 303–320, Universidad del Rosario, Bogota, Colombia, 2013. View at Google Scholar
  7. J.-G. Erdozain, G. Ruiz-Irastorza, M.-V. Egurbide, A. Martinez-Berriotxoa, and C. Aguirre, “High risk of tuberculosis in systemic lupus erythematosus?” Lupus, vol. 15, no. 4, pp. 232–235, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Gonzalez-Gay, C. Gonzalez-Juanatey, and J. Martin, “Rheumatoid arthritis: a disease associated with accelerated atherogenesis,” Seminars in Arthritis and Rheumatism, vol. 35, no. 1, pp. 8–17, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Buttgereit, G. Burmester, and B. J. Lipworth, “Inflammation, glucocorticoids and risk of cardiovascular disease,” Nature Clinical Practice Rheumatology, vol. 5, no. 1, pp. 18–19, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Goldman, S. Gertel, and H. Amital, “Anti-citrullinated peptide antibodies is more than an accurate tool for diagnosis of rheumatoid arthritis,” Israel Medical Association Journal, vol. 15, no. 9, pp. 516–519, 2013. View at Google Scholar
  11. J. E. Fonseca, M. J. Santos, H. Canhão, and E. Choy, “Interleukin-6 as a key player in systemic inflammation and joint destruction,” Autoimmunity Reviews, vol. 8, no. 7, pp. 538–542, 2009. View at Publisher · View at Google Scholar · View at Scopus